Browse drugs

…gnancies from the Roche safety database were analysed. Maternal ocrelizumab exposure was defined as ≥1 infusion; in utero exposure was defi…

…fever, persistent post-ictal confusion and left-sided weakness. Levetiracetam, acyclovir and lacosamide were started, with early investigatio…

…tion of plasma and cells. Removed plasma is often replaced with human albumin solution (HAS). This process is used to treat various neuro-inflammatory…

…costeroids, oral corticosteroids, methotrexate, ciclosporin and azathioprine. Whilst transient improvement was often noted with corticostero…

…duction of k1 and k3 was also evident in these regions. Dynamic Amyloid-PET scans have found comparable metabolic distribution patterns to …

… a patient with enterovirus rhombencephalitis in the context of ocrelizumab treatment for multiple sclerosis.Case A 41 year old female deve…

…e unit utilisation after switching established patients from IV ocrelizumab to SC injection.Methods Patients completed a questionnaire asse…

…sk lesions. Immune checkpoint inhibitors (ICIs) (cemiplimab and pembrolizumab) represent a promising therapeutic option for cases of unresect…

…escribes a study of several European registries on the use of a Phasix mesh in incisional hernia repair. The primary endpoint of the study …

… the sociodemographic and geographical variation in prescribing selective serotonin reuptake inhibitors (SSRIs) and medications for attention-deficit/hyperactivity dis…

… 3 days. It was found that he had been receiving 6000 IU/day of vitamin D for 45 days, with a cumulative dose of 320 000 IU. Laboratory r…

…her G1 (corticosteroid injection+digital rehabilitation) or G2 (corticosteroid injection+traditional home rehabilitation). The primary outcome…